July 2014 Webinar – The Latest News About CRC Research & Treatment

Learn the latest findings from the American Society of Clinical Oncology (ASCO) conference in May. The latest studies, treatments and developments and how they impact colorectal cancer patients were discussed. PRESENTED BY: Cathy Eng, M.D. Associate Professor, Department of Gastrointestinal (GI) Medical OncologyDr. Cathy Eng is Associate Professor in the Department of Gastrointestinal (GI) Medical Oncology at The University…  Read More

Another treatment option coming down the pike: TAS-102

Fight Colorectal Cancer stays actively involved in the research process from beginning to end. Part of our role in research is monitoring the progress of new drugs – drugs that may be used in treatment plans of colorectal cancer in the future. We actively work with drug companies to stay up-to-date on the latest treatments so…  Read More

First-Line Treatment Approved for Stage IV Colorectal Cancer

There is new first-line treatment (standard of care to start treatment) giving as many as 60% of the stage IV colorectal cancer patients more options for treatment. Previously, most stage IV patients undergoing chemotherapy would be recommended to go on FOLFOX and bevacizumab (Avastin). Patients would receive this first set of drugs (called first-line) and if…  Read More

Andi's Highlights on ASCO 2014

by Andi Dwyer, Director of Health Promotion, Fight Colorectal Cancer Working in the cancer prevention and survivorship field for nearly ten years, I was elated to attend my first ASCO.  However, nothing prepared me for the 35,000 people from throughout the world, gathered to unveil the latest in ‘all things’ cancer.  I came in with a notion this…  Read More

April 2014 Webinar: Alphabet Soup – Making Sense out of KRAS, BRAF and Tumor Tests

Have you ever heard any of these acronyms, and wondered what they stand for and how they can affect your treatment plan?  This webinar is designed to help patients better understand biomarkers, and how these biomarkers can affect the treatment options patients receive. We’ll discuss the basic understandings of a cancer cell lives, and how it…  Read More